A detailed history of Pathstone Holdings, LLC transactions in Penumbra Inc stock. As of the latest transaction made, Pathstone Holdings, LLC holds 3,846 shares of PEN stock, worth $907,848. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,846
Previous 4,137 7.03%
Holding current value
$907,848
Previous $744,000 0.27%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$163.64 - $210.12 $47,619 - $61,144
-291 Reduced 7.03%
3,846 $746,000
Q2 2024

Aug 14, 2024

BUY
$172.27 - $223.95 $115,420 - $150,046
670 Added 19.33%
4,137 $744,000
Q1 2024

May 13, 2024

BUY
$220.09 - $273.15 $87,815 - $108,986
399 Added 13.01%
3,467 $773,000
Q4 2023

Feb 14, 2024

BUY
$181.44 - $260.22 $556,657 - $798,354
3,068 New
3,068 $771,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $8.94B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.